MedPath

山西辅仁恒峰药业有限公司

Ownership
-
Established
2016-07-01
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

29

NMPA:29

Drug Approvals

Glucosamine Sulfate Capsules

Product Name
硫酸氨基葡萄糖胶囊
Approval Number
国药准字H20249797
Approval Date
Dec 25, 2024
NMPA

麻仁滋脾丸

Approval Number
国药准字Z20204005
Approval Date
Oct 24, 2024
NMPA

二母宁嗽丸

Approval Number
国药准字Z20194138
Approval Date
Oct 24, 2024
NMPA

牛黄上清丸

Approval Number
国药准字Z20194139
Approval Date
Oct 24, 2024
NMPA

人参养荣丸

Approval Number
国药准字Z20194099
Approval Date
Aug 9, 2024
NMPA

健脾丸

Approval Number
国药准字Z20194095
Approval Date
Aug 9, 2024
NMPA

橘红丸

Approval Number
国药准字Z20194098
Approval Date
Aug 9, 2024
NMPA

通宣理肺丸

Approval Number
国药准字Z20194097
Approval Date
Aug 9, 2024
NMPA

舒肝丸

Approval Number
国药准字Z20194096
Approval Date
Aug 9, 2024
NMPA

清眩丸

Approval Number
国药准字Z20194029
Approval Date
May 7, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.